171 related articles for article (PubMed ID: 35668420)
1. Observational study of population genomic screening for variants associated with endocrine tumor syndromes in a large, healthcare-based cohort.
Savatt JM; Ortiz NM; Thone GM; McDonald WS; Kelly MA; Berry ASF; Alvi MM; Hallquist MLG; Malinowski J; Purdy NC; Williams MS; Sturm AC; Buchanan AH
BMC Med; 2022 Jun; 20(1):205. PubMed ID: 35668420
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes of a genomic screening program for actionable genetic conditions.
Buchanan AH; Lester Kirchner H; Schwartz MLB; Kelly MA; Schmidlen T; Jones LK; Hallquist MLG; Rocha H; Betts M; Schwiter R; Butry L; Lazzeri AL; Frisbie LR; Rahm AK; Hao J; Willard HF; Martin CL; Ledbetter DH; Williams MS; Sturm AC
Genet Med; 2020 Nov; 22(11):1874-1882. PubMed ID: 32601386
[TBL] [Abstract][Full Text] [Related]
3. Healthcare Utilization and Costs after Receiving a Positive
Hao J; Hassen D; Manickam K; Murray MF; Hartzel DN; Hu Y; Liu K; Rahm AK; Williams MS; Lazzeri A; Buchanan A; Sturm A; Snyder SR
J Pers Med; 2020 Feb; 10(1):. PubMed ID: 32028596
[TBL] [Abstract][Full Text] [Related]
4. Identification of Neuropsychiatric Copy Number Variants in a Health Care System Population.
Martin CL; Wain KE; Oetjens MT; Tolwinski K; Palen E; Hare-Harris A; Habegger L; Maxwell EK; Reid JG; Walsh LK; Myers SM; Ledbetter DH
JAMA Psychiatry; 2020 Dec; 77(12):1276-1285. PubMed ID: 32697297
[TBL] [Abstract][Full Text] [Related]
5. Exome Sequencing-Based Screening for BRCA1/2 Expected Pathogenic Variants Among Adult Biobank Participants.
Manickam K; Buchanan AH; Schwartz MLB; Hallquist MLG; Williams JL; Rahm AK; Rocha H; Savatt JM; Evans AE; Butry LM; Lazzeri AL; Lindbuchler DM; Flansburg CN; Leeming R; Vogel VG; Lebo MS; Mason-Suares HM; Hoskinson DC; Abul-Husn NS; Dewey FE; Overton JD; Reid JG; Baras A; Willard HF; McCormick CZ; Krishnamurthy SB; Hartzel DN; Kost KA; Lavage DR; Sturm AC; Frisbie LR; Person TN; Metpally RP; Giovanni MA; Lowry LE; Leader JB; Ritchie MD; Carey DJ; Justice AE; Kirchner HL; Faucett WA; Williams MS; Ledbetter DH; Murray MF
JAMA Netw Open; 2018 Sep; 1(5):e182140. PubMed ID: 30646163
[TBL] [Abstract][Full Text] [Related]
6. Genetics Visit Uptake Among Individuals Receiving Clinically Actionable Genomic Screening Results.
Schwartz MLB; McDonald WS; Hallquist MLG; Hu Y; McCormick CZ; Walters NL; Tsun J; Zimmerman K; Decker A; Gray C; Malinowski J; Sturm AC; Buchanan AH
JAMA Netw Open; 2024 Mar; 7(3):e242388. PubMed ID: 38488794
[TBL] [Abstract][Full Text] [Related]
7. Pediatric reporting of genomic results study (PROGRESS): a mixed-methods, longitudinal, observational cohort study protocol to explore disclosure of actionable adult- and pediatric-onset genomic variants to minors and their parents.
Savatt JM; Wagner JK; Joffe S; Rahm AK; Williams MS; Bradbury AR; Davis FD; Hergenrather J; Hu Y; Kelly MA; Kirchner HL; Meyer MN; Mozersky J; O'Dell SM; Pervola J; Seeley A; Sturm AC; Buchanan AH
BMC Pediatr; 2020 May; 20(1):222. PubMed ID: 32414353
[TBL] [Abstract][Full Text] [Related]
8. Early cancer diagnoses through BRCA1/2 screening of unselected adult biobank participants.
Buchanan AH; Manickam K; Meyer MN; Wagner JK; Hallquist MLG; Williams JL; Rahm AK; Williams MS; Chen ZE; Shah CK; Garg TK; Lazzeri AL; Schwartz MLB; Lindbuchler DM; Fan AL; Leeming R; Servano PO; Smith AL; Vogel VG; Abul-Husn NS; Dewey FE; Lebo MS; Mason-Suares HM; Ritchie MD; Davis FD; Carey DJ; Feinberg DT; Faucett WA; Ledbetter DH; Murray MF
Genet Med; 2018 Apr; 20(5):554-558. PubMed ID: 29261187
[TBL] [Abstract][Full Text] [Related]
9. Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population.
Beck DB; Bodian DL; Shah V; Mirshahi UL; Kim J; Ding Y; Magaziner SJ; Strande NT; Cantor A; Haley JS; Cook A; Hill W; Schwartz AL; Grayson PC; Ferrada MA; Kastner DL; Carey DJ; Stewart DR
JAMA; 2023 Jan; 329(4):318-324. PubMed ID: 36692560
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and Penetrance of Rare Pathogenic Variants in Neurodevelopmental Psychiatric Genes in a Health Care System Population.
Shimelis H; Oetjens MT; Walsh LK; Wain KE; Znidarsic M; Myers SM; Finucane BM; Ledbetter DH; Martin CL
Am J Psychiatry; 2023 Jan; 180(1):65-72. PubMed ID: 36475376
[TBL] [Abstract][Full Text] [Related]
11. A RE-AIM Framework Analysis of DNA-Based Population Screening: Using Implementation Science to Translate Research Into Practice in a Healthcare System.
Jones LK; Strande NT; Calvo EM; Chen J; Rodriguez G; McCormick CZ; Hallquist MLG; Savatt JM; Rocha H; Williams MS; Sturm AC; Buchanan AH; Glasgow RE; Martin CL; Rahm AK
Front Genet; 2022; 13():883073. PubMed ID: 35692820
[No Abstract] [Full Text] [Related]
12. Genetic testing and surveillance guidelines in hereditary pheochromocytoma and paraganglioma.
Muth A; Crona J; Gimm O; Elmgren A; Filipsson K; Stenmark Askmalm M; Sandstedt J; Tengvar M; Tham E
J Intern Med; 2019 Feb; 285(2):187-204. PubMed ID: 30536464
[TBL] [Abstract][Full Text] [Related]
13. Arrhythmia Variant Associations and Reclassifications in the eMERGE-III Sequencing Study.
Glazer AM; Davogustto G; Shaffer CM; Vanoye CG; Desai RR; Farber-Eger EH; Dikilitas O; Shang N; Pacheco JA; Yang T; Muhammad A; Mosley JD; Van Driest SL; Wells QS; Shaffer LL; Kalash OR; Wada Y; Bland HT; Yoneda ZT; Mitchell DW; Kroncke BM; Kullo IJ; Jarvik GP; Gordon AS; Larson EB; Manolio TA; Mirshahi T; Luo JZ; Schaid D; Namjou B; Alsaied T; Singh R; Singhal A; Liu C; Weng C; Hripcsak G; Ralston JD; McNally EM; Chung WK; Carrell DS; Leppig KA; Hakonarson H; Sleiman P; Sohn S; Glessner J; ; Denny J; Wei WQ; George AL; Shoemaker MB; Roden DM
Circulation; 2022 Mar; 145(12):877-891. PubMed ID: 34930020
[TBL] [Abstract][Full Text] [Related]
14. Pathogenicity of DNA variants and double mutations in multiple endocrine neoplasia type 2 and von Hippel-Lindau syndrome.
Erlic Z; Hoffmann MM; Sullivan M; Franke G; Peczkowska M; Harsch I; Schott M; Gabbert HE; Valimäki M; Preuss SF; Hasse-Lazar K; Waligorski D; Robledo M; Januszewicz A; Eng C; Neumann HP
J Clin Endocrinol Metab; 2010 Jan; 95(1):308-13. PubMed ID: 19906784
[TBL] [Abstract][Full Text] [Related]
15. A Genome-First Approach to Characterize DICER1 Pathogenic Variant Prevalence, Penetrance, and Phenotype.
Mirshahi UL; Kim J; Best AF; Chen ZE; Hu Y; Haley JS; Golden A; Stahl R; Manickam K; Carr AG; Harney LA; Field A; Hatton J; Schultz KAP; Bauer AJ; Hill DA; Rosenberg PS; Murray MF; Carey DJ; Stewart DR
JAMA Netw Open; 2021 Feb; 4(2):e210112. PubMed ID: 33630087
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes.
Gill AJ; Benn DE; Chou A; Clarkson A; Muljono A; Meyer-Rochow GY; Richardson AL; Sidhu SB; Robinson BG; Clifton-Bligh RJ
Hum Pathol; 2010 Jun; 41(6):805-14. PubMed ID: 20236688
[TBL] [Abstract][Full Text] [Related]
17. Secondary (additional) findings from the 100,000 Genomes Project: Disease manifestation, health care outcomes, and costs of disclosure.
Nolan J; Buchanan J; Taylor J; Almeida J; Bedenham T; Blair E; Broadgate S; Butler S; Cazeaux A; Craft J; Cranston T; Crawford G; Forrest J; Gabriel J; George E; Gillen D; Haeger A; Hastings Ward J; Hawkes L; Hodgkiss C; Hoffman J; Jones A; Karpe F; Kasperaviciute D; Kovacs E; Leigh S; Limb E; Lloyd-Jani A; Lopez J; Lucassen A; McFarlane C; O'Rourke AW; Pond E; Sherman C; Stewart H; Thomas E; Thomas S; Thomas T; Thomson K; Wakelin H; Walker S; Watson M; Williams E; Ormondroyd E
Genet Med; 2024 Mar; 26(3):101051. PubMed ID: 38131308
[TBL] [Abstract][Full Text] [Related]
18. Tumor detection rates in screening of individuals with SDHx-related hereditary paraganglioma-pheochromocytoma syndrome.
Greenberg SE; Jacobs MF; Wachtel H; Anson A; Buchmann L; Cohen DL; Bonanni M; Bennett B; Naumer A; Schaefer AM; Kohlmann W; Nathanson KL; Else T; Fishbein L
Genet Med; 2020 Dec; 22(12):2101-2107. PubMed ID: 32741965
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and genetic testing outcomes of patients with clinically suspected paraganglioma/pheochromocytoma (PGL/PCC) syndrome in Singapore.
Ting KR; Ong PY; Wei SOG; Parameswaran R; Khoo CM; Deepak DS; Lee SC
Hered Cancer Clin Pract; 2020 Dec; 18(1):24. PubMed ID: 33308260
[TBL] [Abstract][Full Text] [Related]
20. Leveraging population-based exome screening to impact clinical care: The evolution of variant assessment in the Geisinger MyCode research project.
Kelly MA; Leader JB; Wain KE; Bodian D; Oetjens MT; Ledbetter DH; Martin CL; Strande NT
Am J Med Genet C Semin Med Genet; 2021 Mar; 187(1):83-94. PubMed ID: 33576083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
